Evidence that the immunopathogenic mechanism of lithium‐induced psoriasis differs from that of regular psoriasis
- 15 July 2005
- journal article
- Published by Wiley in Bipolar Disorders
- Vol. 7 (4) , 388-389
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cytokines: interleukin and interferon therapy in dermatologyClinical and Experimental Dermatology, 2002
- Is Lithium Still Worth Using? An Update of Selected Recent ResearchHarvard Review of Psychiatry, 2002
- Is Lithium Still Worth Using? An Update of Selected Recent ResearchHarvard Review of Psychiatry, 2002
- Psoriasis vulgaris - a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasisClinical and Experimental Dermatology, 2001
- Effects of lithium carbonate (Li2CO3) on in‐vitro‐cultured normal human skin explantsJournal of the European Academy of Dermatology and Venereology, 2000
- A control study of the cutaneous side effects of chronic lithium therapyJournal of Affective Disorders, 2000
- The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermisThe Journal of Immunology, 1997
- CD1a+ and CD1a- Accessory Cells from Human Bronchoalveolar Lavage Differ in Allostimulatory Potential and Cytokine ProductionAmerican Journal of Respiratory Cell and Molecular Biology, 1996
- The role of cytokines in the psoriatic inflammationJournal of Dermatological Science, 1993